Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 3 May 1996:
Vol. 272. no. 5262, pp. 699 - 0
DOI: 10.1126/science.272.5262.699
Prev | Table of Contents | Next

Perspectives

Daniel Porte Jr., Michael W. Schwartz

Individuals with diabetes can lead quite normal lives when their blood sugar is controlled by insulin injections. But these injections cannot maintain blood glucose at concentrations as low and stable as they are in normal individuals. The resulting highe r glucose concentrations eventually lead to the complications of diabetes--damage to blood vessels, heart disease, blindness, stroke, and kidney failure. In a report in this week's issue (Ishii et al., p. 728), a new inhibitor of protein kinase C is shown to inhibit some indices of glucose toxicity in an animal model of diabetes. In their Perspective, Porte and Schwartz discuss how close we are to being able to treat these complication s in patients.

The authors are in the Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, Department of Veteran Affairs Puget Sound Health Care System and University of Washington, Seattle, WA 98108, USA. E-mail: dporte@u.washington.edu


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Dietary Exposure to 2-Aminoanthracene Induces Morphological and Immunocytochemical Changes in Pancreatic Tissues of Fisher-344 Rats.
M. D. Boudreau, H. W. Taylor, D. G. Baker, and J. C. Means (2006)
Toxicol. Sci. 93, 50-61
   Abstract »    Full Text »    PDF »
Riluzole Inhibits VEGF-Induced Endothelial Cell Proliferation In Vitro and Hyperoxia-Induced Abnormal Vessel Formation In Vivo.
M. H. Yoo, H.-J. Hyun, J.-Y. Koh, and Y. H. Yoon (2005)
Invest. Ophthalmol. Vis. Sci. 46, 4780-4787
   Abstract »    Full Text »    PDF »
Review: Preventing End-Stage Renal Disease in Diabetic Patients -- Dual Blockade of the Renin-Angiotensin System (Part II).
P. K. Jacobsen (2005)
Journal of Renin-Angiotensin-Aldosterone System 6, 55-68
   Abstract »    PDF »
Preventing end stage renal disease in diabetic patients -- genetic aspect (part I).
P. K. Jacobsen (2005)
Journal of Renin-Angiotensin-Aldosterone System 6, 1-14
   Abstract »    PDF »
Intensive Insulin Therapy for Critically Ill Patients.
K. S Lewis, S. L Kane-Gill, M. B. Bobek, and J. F Dasta (2004)
Ann. Pharmacother. 38, 1243-1251
   Abstract »    Full Text »    PDF »
Acute Hyperglycemia: Implications for contrast-induced nephropathy during cardiac catheterization.
D. B. Turcot, F. J. Kiernan, R. G. McKay, N. J. Grey, W. Boden, and G. A. Perdrizet (2004)
Diabetes Care 27, 620-621
   Full Text »    PDF »
Increased expression of cyclooxygenase-1 and -2 in the diabetic rat renal medulla.
R. Nasrallah, A. Landry, S. Singh, M. Sklepowicz, and R. L. Hebert (2003)
Am J Physiol Renal Physiol 285, F1068-F1077
   Abstract »    Full Text »
Leptin and Wound Inflammation in Diabetic ob/ob Mice: Differential Regulation of Neutrophil and Macrophage Influx and a Potential Role for the Scab as a Sink for Inflammatory Cells and Mediators.
I. Goren, H. Kampfer, M. Podda, J. Pfeilschifter, and S. Frank (2003)
Diabetes 52, 2821-2832
   Abstract »    Full Text »    PDF »
Glucose-Induced TGF-{beta}1 and TGF-{beta} Receptor-1 Expression in Vascular Smooth Muscle Cells Is Mediated by Protein Kinase C-{alpha}.
C. Lindschau, P. Quass, J. Menne, F. Guler, A. Fiebeler, M. Leitges, F. C. Luft, and H. Haller (2003)
Hypertension 42, 335-341
   Abstract »    Full Text »    PDF »
Protein Kinase C{beta} Selective Inhibitor LY333531 Attenuates Diabetic Hyperalgesia Through Ameliorating cGMP Level of Dorsal Root Ganglion Neurons.
H. Kim, T. Sasaki, K. Maeda, D. Koya, A. Kashiwagi, and H. Yasuda (2003)
Diabetes 52, 2102-2109
   Abstract »    Full Text »    PDF »
Glucose Effects on Skin Keratinocytes: Implications for Diabetes Skin Complications.
N. Spravchikov, G. Sizyakov, M. Gartsbein, D. Accili, T. Tennenbaum, and E. Wertheimer (2001)
Diabetes 50, 1627-1635
   Abstract »    Full Text »    PDF »
Hyperglycemia Acutely Increases Monocyte Extracellular Signal-Regulated Kinase Activity in Vivo in Humans.
G. Ceolotto, A. Gallo, M. Sartori, R. Valente, E. Baritono, A. Semplicini, and A. Avogaro (2001)
J. Clin. Endocrinol. Metab. 86, 1301-1305
   Abstract »    Full Text »
Extracellular Signal-Regulated Kinase Mediates Stimulation of TGF-{beta}1 and Matrix by High Glucose in Mesangial Cells.
M. ISONO, M. C. I.-D. L. CRUZ, S. CHEN, S. W. HONG, and F. N. ZIYADEH (2000)
J. Am. Soc. Nephrol. 11, 2222-2230
   Abstract »    Full Text »
Glycated albumin stimulation of PKC-beta activity is linked to increased collagen IV in mesangial cells.
M. P. Cohen, F. N. Ziyadeh, G. T. Lautenslager, J. A. Cohen, and C. W. Shearman (1999)
Am J Physiol Renal Physiol 276, F684-F690
   Abstract »    Full Text »    PDF »
Acute hyperglycemia abolishes ischemic preconditioning in vivo.
J. R. Kersten, T. J. Schmeling, K. G. Orth, P. S. Pagel, and D. C. Warltier (1998)
Am J Physiol Heart Circ Physiol 275, H721-H725
   Abstract »    Full Text »    PDF »
Changes in protein kinase C in early cardiomyopathy and in gracilis muscle in the BB/Wor diabetic rat.
T. D. Giles, J. Ouyang, E. K. Kerut, M. B. Given, G. E. Allen, E. F. McIlwain, and S. S. Greenberg (1998)
Am J Physiol Heart Circ Physiol 274, H295-H307
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)